Haemorheological, endothelial and platelet function in subjects with hypertension: relationship to cardiovascular risk and influence of antihypertensive treatment.
Spencer
C G
CG
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK.
Beevers
D G
DG
Lip
G Y
GY
D000959:Antihypertensive Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001809:Blood Viscosity; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy; D003430:Cross-Sectional Studies; D005260:Female; D005340:Fibrinogen / Q000187:drug effects / Q000502:physiology; D006400:Hematocrit; D018056:Hemorheology; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000188:drug therapy; D008297:Male; D019007:P-Selectin / Q000187:drug effects; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000188:drug therapy; D014841:von Willebrand Factor / Q000187:drug effects / Q000502:physiology
D000959:Antihypertensive Agents; D015415:Biomarkers; D019007:P-Selectin; D014841:von Willebrand Factor; D005340:Fibrinogen